New HIV Guidelines Encourage Regular Health Check-Ups
New advancements in HIV treatment have allowed many people to live with a very small amount of the virus in their bodies. But what are the pros and cons?
HIV Boosted Bone Fracture Risk
HIV/AIDS treatment has helped lengthen patients' lives. But as they live longer, people with HIV may have to be especially watchful for health problems related to age, including the possibility of weaker bones.
Organs From High Risk Patients May Be Okay for Donation
People at risk for certain infectious diseases are usually disqualified from being blood donors. However, new research suggests that they may still be safe organ donors.
Using Fewer Clinics May Be Better for HIV Care
Reliable and consistent care for HIV-infected people is a necessity. Using multiple care centers for treatment may not allow patients to get the right amount or kind of care.
UNAIDS Releases HIV Progress Report
HIV/AIDS has affected millions of people around the world for the past few decades. And now it's in steady decline.
How Does HIV Affect Menopause?
Recent advances in HIV treatment have allowed more HIV-infected women to live through and past menopause. But not much is known about the effects of HIV on menopause.
Who Should Get Tested For HIV?
Early detection of human immunodeficiency virus (HIV) is extremely important because disease management will be easier, more efficient and cost less. But how do you know if you should get tested?
Rx to Protect HIV Patients from TB
People with HIV have weakened immune systems, so they are more likely to catch harmful diseases like tuberculosis. However, new research suggests that a certain prevention therapy could significantly reduce that risk.
The Benefits of Exercise for Adults with HIV
There have been advances in HIV treatment in recent years, yet nearly half of all people infected with HIV experience life-changing, reduced brain function. New research suggests that exercise could make a big difference for these patients.
FDA Approves New Drug to Treat HIV Infection
The US Food and Drug Administration today approved Tivicay ( dolutegravir ), a new drug to treat HIV-1 infection.